The efficacy of scalp nerve block using 0.5% bupivacaine with adrenaline for postoperative pain relief in craniotomy patients was evaluated in 40 ASA I or II adult patients undergoing supratentorial craniotomy. A standard general anaesthesia technique was followed. Patients were randomly divided into two groups. Group B received 0.5% bupivacaine with 1:400,000 adrenaline and group S received normal saline with 1:400,000 adrenaline, both after skin closure. Postoperative pain was assessed at 30 seconds and 1, 2, 4, 6, 8 and 12 hours using a numerical rating scale. Diclofenac IM was administered as rescue analgesia if patients reported a numerical rating scale of 40 or more. Tramadol IV was administered as second rescue analgesia. Sixty per cent of patients in group S experienced moderate to severe pain (numerical rating scale of 40 or more) at some time during the first 12 postoperative hours in comparison to 25% patients in group B. Median pain scores were significantly lower in group B for up to 6 hours. Significantly more patients were pain free up to four hours in group B. Median duration for the requirement of first dose of diclofenac was longer in group B compared to group S (360 min vs 30 min, P<0.01). The number of doses of diclofenac (5 vs 19) was significantly lower in group B compared to group S (P<0.01). Tramadol was required by six patients in group S only. Scalp nerve block using 0.5% bupivacaine with 1:400,000 adrenaline decreases the incidence and severity of postoperative pain in patients undergoing supratentorial craniotomy.
Postoperative pain is common in neurosurgical patients and is often undertreated for the fear of masking neurosurgical pathology or depressing ventilation 1 . opioids like morphine 2 , tramadol 3 and codeine 4 have been utilized for pain relief. however, they are associated with side-effects. A regional anaesthesia technique might be a better choice for pain relief in these patients, as side-effects associated with the systemic drugs can be avoided.
the scalp is densely innervated by C fibres and the main cause of postoperative pain in patients following craniotomy is the skin incision and reflection of muscles during the operation rather than brain manipulation and resection 5 . Blockade of nerves that supply the scalp will anaesthetize both superficial and deep layers of the scalp. Studies of the effect of regional anaesthesia on postoperative pain after intracranial surgery are scarce. wound infiltration 6, 7 and superficial cervical plexus block 8 with local anaesthetic have been used to decrease postoperative pain after craniotomy. only one previous study with ropivacaine has examined the effect of scalp block on post-craniotomy pain 9 .
we planned this prospective double-blind randomized study to assess the efficacy of scalp block using 0.5% bupivacaine with 1:400,000 adrenaline for postoperative pain relief after craniotomy.
MAtERIAlS ANd MEthodS
After institutional ethics committee approval and informed patient consent, 40 ASA I and II patients, aged 18 to 50 years undergoing elective supratentorial craniotomy were included in the study. Patients with a Glasgow Coma Score (GCS) less than 15, those with documented allergy to bupivacaine, and those undergoing emergency procedures were excluded.
All patients were examined on the evening before surgery and familiarized with the numerical rating scale (NRS) 11 for pain assessment. Patients were advised to select a number from 0 to 100 to describe the intensity of their postoperative pain. Zero in-dicated no pain and 100 indicated the worst possible pain. Baseline blood pressure and heart rate were recorded. All patients were premedicated with oral diazepam 5 mg the night before surgery and 5 mg in the morning on the day of surgery.
A standard anaesthetic technique was followed. After preoxygenation for three minutes, anaesthesia was induced with thiopentone 5 mg/kg. Vecuronium was used to provide muscle relaxation. Anaesthesia was maintained with 66% nitrous oxide in oxygen and isoflurane 0.5-1% supplemented with intravenous morphine 0.15 mg/kg IV. At the end of the procedure, neuromuscular blockade was reversed with neostigmine 0.05 mg/kg and atropine 0.02 mg/kg. Patients were extubated when they were able to obey simple commands.
After skin closure, the scalp block was performed using aseptic precautions. Patients were randomly divided into two groups using a computer generated random number chart. Group B received scalp block with 0.5% bupivacaine and adrenaline 1:400,000, whereas group S received scalp block using normal saline with 1:400,000 adrenaline. the neurosurgeon, the anaesthetist performing the scalp block and the patients were blinded to the drug being administered. the anaesthetist performing the block did not participate in the postoperative pain assessment.
the scalp block was performed as described by Pinosky et al 12 . the following nerves were blocked bilaterally: the supraorbital and supratrochlear nerves were blocked as they emerge from the orbit with 2 ml of solution using a 23G needle introduced above the eyebrow perpendicular to the skin; the auriculotemporal nerves were blocked with 2 ml of solution injected 1.5 cm anterior to the ear at the level of tragus (the 23G needle was introduced perpendicular to the skin and injection was made deep to the fascia and superficially as the needle was withdrawn); the zygomatico-temporal nerves were blocked midway between the supraorbital and auriculo-temporal nerves by using 2 ml of solution with a 23G needle; the postauricular branches of the greater auricular nerves were blocked by 2 ml of solution using a 23G needle between the skin and bone 1.5 cm posterior to the ear at the level of tragus; the greater, lesser and third occipital nerves were blocked with 2 ml of solution using a 22G spinal needle with infiltration along the superior nuchal line, approximately halfway between the occipital protuberance and mastoid process. the total volume of solution used was 20 ml in all patients.
Postoperative analgesia was assessed using NRS at time intervals of 30 minutes and 1, 2, 4, 6, 8 and 12 hours postoperatively. other parameters recorded were blood pressure, heart rate, respiratory rate, GCS and sedation score. Sedation was assessed using four point scale: i.e. 1. awake and communicative; 2. asleep, responds to normal speech; 3. asleep, responds to shaking; 4. deeply sedated. Patients having an NRS≥40 were treated with diclofenac 75 mg IM as first rescue analgesic. tramadol 50 mg IV was used as second rescue analgesic if the NRS remained at 40 in spite of receiving diclofenac. the time interval between the end of surgery and the first requirement of rescue analgesic was noted for each patient. total dose and frequency of rescue analgesics administered was also noted.
Sample size calculation was performed, based on the assumption that scalp block will decrease the incidence of moderate to severe postoperative pain (NRS≥40) by 50% (from 80 to 40%). with a of 0.05 and power of 80%, 19 patients in each group were required. therefore we chose 20 patients per group in the study.
Pain and sedation scores were compared using wilcoxon test. the numbers of pain free patients at different time intervals were compared using chi square test or Fisher's exact test. the time interval between the end of surgery and the first administration of diclofenac was compared using Mann whitney u test. dose requirement of diclofenac was compared using chi square test and that of tramadol was compared using Fisher exact test between the groups. A P value <0.01 was considered significant.
RESultS
the demographic characteristics and duration of surgery are provided in table 1. the indications for craniotomies performed for each group are given in table 2. Sixty per cent of patients in group S experienced moderate to severe pain (NRS≥40) at some time during the first 12 postoperative hours in comparison to 25% patients in group B. the median pain scores were significantly lower up to six hours postoperatively in group B (table 3) . More patients in group B were pain free compared to group S at all time intervals. however, the difference was significant only until four hours (table 4). Most of the patients were awake or easily arousable in the immediate postoperative period. All patients were extubated on the operating table once they followed verbal commands. Sedation scores were comparable between the groups at all time intervals.
No arrhythmia or hypotension was noted during block administration or in the postoperative period. dISCuSSIoN the conventional wisdom that most neurosurgical patients experience minimal postoperative pain and require little analgesia has been challenged. In contrast to the standard teaching that pain is not a significant problem in craniotomy patients 13 , recent studies have reported that 60 to 84% of patients experience moderate to severe pain after craniotomy 5, 10 .
the scalp is densely innervated by sensory nerves. the forehead and front of the scalp are supplied by the supraorbital and supratrochlear nerves (branches of ophthalmic division of trigeminal) the temple by auriculotemporal (branch of mandibular division of trigeminal) and zygomatico-temporal nerves (branch of maxillary division of trigeminal). Posteriorly the greater occipital and third occipital nerves (posterior rami of C2 and C3 respectively) extend to the vertex and posterior scalp respectively. the lesser occipital (anterior ramus of C2) supplies the skin behind the ear.
In a few prospective studies carried out to assess the incidence and severity of postcraniotomy pain, it was observed that 60 to 84% patients reported moderate to severe or even excruciating pain during the first 24 hours 5, 10 . In our study, 60% of patients in our saline group experienced moderate to severe pain at some time during the first 12 postoperative hours. hence, ours is another study that indicates that moderate to severe pain is common in patients following craniotomy.
we found that blockade of the main sensory nerves of the scalp with bupivacaine and adrenaline was effective in decreasing postoperative pain in patients who underwent supratentorial craniotomy. only 25% patients in group B had moderate to severe pain during the first 12 hours. Patients in group B had lower pain scores for up to six hours postoperatively.
the duration of pain relief in our study corresponded with the expected duration of action of bupivacaine with adrenaline. this is in contrast with a previous study by Nguyen et al 9 who used ropivacaine 0.75% for scalp nerve block for postcraniotomy pain relief. they observed that the duration of pain relief was much longer than the expected duration of action of ropivacaine (three to four hours). their average pain scores in the ropivacaine groups were significantly lower compared to the saline group up to 24 hours and the analgesic effect seemed to persist for at least 48 hours postoperatively. the authors i. bala, b. GupTa eT al attributed this unexpected long-lasting analgesia to pre-emptive analgesic effect. No such phenomenon was observed in our study. the time interval between the end of the surgery and demand of first dose of rescue analgesic was significantly longer in group B compared to the group S. the number of doses and the total dose of diclofenac required was also significantly less in group B. this is not consistent with the observations of Nguyen et al 9 . they observed that although there was a trend towards a longer time interval between the end of surgery and the first dose of rescue analgesia (codeine) in the ropivacaine group, it did not reach statistical significance. the total dose of codeine administered was also not significantly different between the groups. the difference between their study and our study results could be because of the analgesic regimen chosen. Nguyen et al 9 used codeine phosphate (0.5-1.0 mg/kg) at a fixed interval of three to four hours as requested by the patients in both the groups despite lower visual analogue scores in their ropivacaine group. however, we administered rescue analgesia only if the NRS was ≥40. In our study, the choice of diclofenac as first rescue analgesic and tramadol as second rescue analgesic was based on the regimen being followed by our neurosurgeon colleagues.
Scalp infiltration with local anaesthetic is another technique that has been studied for postoperative pain after craniotomy. Bloomfield et al 6 infiltrated the scalp both before incision and after scalp closure with 0.25% bupivacaine with 1:200,000 adrenaline. their study was limited to only one hour in the immediate postoperative period and showed that wound infiltration decreases pain scores on admission to PACu up to one hour. In a more recent study, Biswas and Bithal 7 observed that although preincision scalp infiltration with bupivacaine did not have any significant effect on postcraniotomy pain and analgesic requirement, it delayed the need for rescue analgesia.
we chose bupivacaine because of its longer duration of action. Adrenaline 1:400,000 was added to further prolong its action and reduce the risk of toxicity. Bupivacaine with adrenaline has been used previously for scalp infiltration without any increase in mean arterial pressure or heart rate 14 . we also did not observe any change in heart rate or blood pressure.
It has been observed by Castello et al 15 that scalp block with ropivacaine (mean dose 3.6 mg/kg) used for awake craniotomies, was associated with rapid rise in plasma levels of ropivacaine which peaked at about 15 minutes after injection. despite this rapid rise, no signs of cardiovascular or central nervous toxicity were observed. Although blood levels of bupivacaine were not measured in our study, no patient had signs or symptoms of bupivacaine toxicity.
In conclusion, this study demonstrates that scalp block using 0.5% bupivacaine with adrenaline decreases both the incidence and severity of postoperative pain in patients undergoing supratentorial craniotomy.
